HUTCHMED (China) Limited revenue breakdown overview

HUTCHMED (China) Limited revenue for the last year amounted to 630.20 M USD, the most of which — 271.53 M USD — came from its highest performing source at the moment, Oncology/Immunology - Marketed Products, the year earlier bringing 164.16 M USD. The greatest contribution to the revenue figure was made by China — last year it brought HUTCHMED (China) Limited 452.41 M USD, and the year before that — 484.89 M USD.